Rapid Dose Therapeutics Corp. (CSE:DOSE)

Canada flag Canada · Delayed Price · Currency is CAD
0.2100
+0.0100 (5.00%)
Jun 27, 2025, 3:59 PM EDT
13.51%
Market Cap 27.70M
Revenue (ttm) 2.09M
Net Income (ttm) -5.40M
Shares Out 131.89M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 44,087
Open 0.2100
Previous Close 0.2000
Day's Range 0.2100 - 0.2100
52-Week Range 0.1250 - 0.3250
Beta -0.21
RSI 51.12
Earnings Date Jun 27, 2025

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products.... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mark Upsdell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DOSE
Full Company Profile

Financial Performance

In 2024, Rapid Dose Therapeutics's revenue was 2.09 million, an increase of 104.34% compared to the previous year's 1.02 million. Losses were -5.40 million, 25.5% more than in 2023.

Financial Statements

News

There is no news available yet.